Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$63K Sell
3,274
-846
-21% -$15.1K 0.29% 183
2020
Q2
$127K Buy
+4,120
New +$72.3K 0.09% 192
2019
Q2
Sell
-15,049
Closed -$321K 428
2019
Q1
$321K Buy
15,049
+2,807
+23% +$62.9K 0.28% 245
2018
Q4
$256K Buy
+12,242
New +$318K 0.18% 139
2018
Q3
Sell
-5,757
Closed -$154K 421
2018
Q2
$154K Sell
5,757
-2,324
-29% -$64.2K 0.26% 317
2018
Q1
$231K Buy
8,081
+3,961
+96% +$121K 0.3% 11
2017
Q4
$127K Buy
+4,120
New +$126K 0.09% 192

Other funds holding ARMK

Cerebellum's ARMK Position: Q3 2020 in Review

Cerebellum reduced its Aramark (ARMK) stake by 21% in Q3 2020, selling an estimated $15.1K and leaving 3,274 shares worth $63K. The position accounts for 0.29% of the portfolio, ranked #183.

Cerebellum first reported a position in ARMK in Q4 2017 and has held it in 7 quarters since. The position peaked at $321K in Q1 2019. 308 funds tracked by Wall St. Rank hold ARMK as of Q3 2020.

  • Cerebellum held 3,274 shares of Aramark worth $63K as of Q3 2020.
  • Cerebellum sold 846 Aramark shares in Q3 2020, an estimated $15.1K.
  • Aramark made up 0.29% of Cerebellum's portfolio in Q3 2020, its #183 holding.
  • Cerebellum first reported a position in Aramark in Q4 2017 and has held it in 7 quarters since.
  • Cerebellum's Aramark position peaked at $321K in Q1 2019.
  • 308 funds tracked by Wall St. Rank held Aramark as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.